
Pfizer 's ( PFE ) price target is hiked a buck to $29 at MKM Partners as the earlier-than-expected Zoetis ( ZTS ) spinoff has the team cutting
By Alpha Hunter: Pfizer ( PFE ) is the world's largest research-based pharmaceutical company. It discovers, manufactures and leads the global market in
Fierce had a recent article on marketing budgets in the business, and they take Pfizer 's ( PFE ) numbers as a test case. That's actually a really good example: Pfizer is known as a mighty marketing machine, and for a long time they had what must
Renauer: My last article concerning MannKind Corp. ( MNKD ) was a discussion of how its Afrezza will succeed where Pfizer 's ( PFE ) Exubera failed. I still believe it can, but I didn't give MannKind's competitive landscape as much attention
is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer .
CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer .
is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer .
May 22 (Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7...
(Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis stock at a 7 percent discount.
NEW YORK, May 22 (Reuters) - Pfizer Inc : * Up 2.2 percent to $29.40 in premarket after plans to unwind remaining majority stake in Zoetis